The daily job of a pharmacist can be full of time-consuming manual processes. Inefficient workflows and lack of data visibility compound Pharmacy challenges. Leveraging medication inventory management tools are helping many health systems like Wellforce to improve efficiency through automated workflows and real-time data that allow pharmacists to provide top of license care.
Hospitals that continue to manually manage medications in the central pharmacy are playing a dangerous game. Inevitably a medication management error will happen. Yet for many hospitals, the fear of change keeps many pharmacies stuck with archaic solutions and processes that inevitably lead to problems.
After a long period of treading water, recent developments in federal court bode well for 340B providers trying to restore access to 340B pricing in the contract pharmacy setting. A close review of recent government court filings also provides a strong endorsement for a key but highlydebated tenet of the 340B program.
The recent State of Pharmacy Compounding survey found that outsourcing for CSPs continues to remain high. But with disruption and uncertainty in the safety and supply of outsourced compounded IV medication, insourcing with IV technology is a strategy that health systems need to consider.
The Institute for Safe Medication Practices has established best practice guidelines for specific medication safety issues that continue to cause fatal and harmful errors in patients. The goal is to support the safety of the medication distribution process while making required drugs readily accessible in a variety of patient care areas.
Pharmacists are consistently ranked among the top-most trusted professions. But under-utilization of the pharmacist is resulting in a significant lost opportunity for clinical excellence and patient satisfaction. The digital transformation of healthcare is the opportunity for pharmacy to move back to the center of culturally competent patient care.
For nearly 30 years, the 340B Drug Pricing Program has provided vital financial support to nonprofit hospitals and is now considered an important element of hospital finance in many communities. But a variety of industry and regulatory pressures are making the program increasingly complex. What was once easily managed within the hospital pharmacy department now frequently requires a cross-functional approach involving the hospital finance department, hospital operations and healthcare providers.
There have already been numerous actions in the various legal cases surrounding the 340B drug discount program, including motions to dismiss, requests to intervene, requests for a stay, granting of a stay, joint status reports, friend of the court filings and requests for additional briefings, to name a few. The pharmaceutical industry has been the winner so far on procedural issues.
The OR is one of the most dynamic environments across any health system. In this space, where patient acuity is high and the process for medication use is highly regulated, anesthesia providers must remain single-mindedly focused on patient care – not administrative tasks. At the same time, pharmacy needs to maintain a strong chain of custody for controlled substances.
The Autonomous Pharmacy Advisory Board has coalesced around the clear vision of a fully autonomous pharmacy. Recent AJHP commentary details a framework that identifies five levels of increasing technological capability and work process improvement spanning nine pharmacy work processes. The ultimate goal is near error-free medication management that optimizes the benefits and minimizes the harm and costs of medication use.
Local pharmacists have always strived to be more than medication dispensers. With the onset of the COVID-19 pandemic, pharmacists now have the opportunity to practice at the top of their license, offering comforting support and vital healthcare expertise right next door.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.